Sitemap

January 10, 2005 Articles

Filter by Available Specialty
  1. B&L will license Plasmin for ophthalmic use
  2. Menstrual cycle may affect visual field outcomes
  3. Optic abnormalities may be indicative of early-onset PKAN
  4. Visual field ‘sum of slopes’ can predict VF progression